Skip to Main Content

Paper Details

Structural variants shape driver combinations and outcomes in pediatric high-grade glioma.
Nat Cancer
17
2022
Author NameAffiliation
Travis I ZackDana-Farber Cancer Institute and Harvard Medical School
Travis I ZackBroad Institute of MIT and Harvard
Jeremiah WalaDana-Farber Cancer Institute and Harvard Medical School
Jeremiah WalaBroad Institute of MIT and Harvard
Jeremiah WalaDana-Farber Cancer Institute and Harvard Medical School
Jeremiah WalaBroad Institute of MIT and Harvard
Hayley MalkinDana-Farber Cancer Institute, Harvard Medical School
Ryan O'RourkeDana-Farber Cancer Institute and Harvard Medical School
Ryan O'RourkeBroad Institute of MIT and Harvard
Jacques GrillDepartment of Pediatric and Adolescent Oncology and INSERM Unit , Gustave Roussy Institute and University of Paris Saclay
Liliana C GoumnerovaBoston Children's Hospital Dana Farber/Boston Children's Cancer and Blood Disorders Center
Liliana C Goumnerova
Nada JabadoMcGill University
Nada JabadoMcGill University, and The Research Institute of the McGill University Health Centre
Nada JabadoMcGill University
Nada JabadoMcGill University, and The Research Institute of the McGill University Health Centre
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
Mark W KieranBroad Institute of MIT and Harvard
Mark W KieranHarvard Medical School
Mark W Kieran
Mark W Kieran
Mark W KieranBroad Institute of MIT and Harvard
Mark W KieranHarvard Medical School
Mark W Kieran
Mark W Kieran
Keith L LigonBroad Institute of MIT and Harvard
Keith L LigonDana-Farber Cancer Institute, Harvard Medical School
Keith L LigonBrigham & Women's Hospital and Boston Children's Hospital
Keith L LigonCenter for Patient Derived Models, Dana-Farber Cancer Institute
Rameen BeroukhimDana-Farber Cancer Institute and Harvard Medical School
Rameen BeroukhimBroad Institute of MIT and Harvard
Rameen BeroukhimDana-Farber Cancer Institute and Harvard Medical School
Pratiti BandopadhayayBroad Institute of MIT and Harvard
Pratiti BandopadhayayHarvard Medical School
Pratiti Bandopadhayay
  • 1 - 38

Datasets

Release 1.2